Overview
Cegedim offers various services in the health care industry including software & services, business process outsourcing, digitalization, and marketing, among other things. The company provides market research and technology services to pharmaceutical companies and health care providers in more than 10 countries. The company is able to operate through its more than 6,000 employees. In addition, the company aims to create a unique healthcare ecosystem,
...
Read More connecting the patient to pharmacies, researchers, health authorities, and other care providers. Cegedim was founded in 1969.
Read Less
Read More connecting the patient to pharmacies, researchers, health authorities, and other care providers. Cegedim was founded in 1969.
Read Less
Jean-Claude LABRUNE
See more contacts
Computer Systems Design and Related Services
,
Professional, Scientific, and Technical Services
,
Computer related services, nec
Accounting, Tax Preparation, Bookkeeping, and Payroll Services
,
Advertising, Public Relations, and Related Services
,
Architectural, Engineering, and Related Services
,
Legal Services
,
Management, Scientific, and Technical Consulting Services
,
Other Professional, Scientific, and Technical Services
,
Scientific Research and Development Services
,
Specialized Design Services
?
?
?
Actual
?
Actual
$692.13 million
Actual
6.25%
$986
DEC
?
?
Euronext Paris:CGM
Contacts
Get in Touch with 10 Principals*
-
Jean-Claude LABRUNEChairman of the Board and General Manager and Board Member
-
Contact 2?
-
Contact 3?
-
Contact 4?
Dynamic search and list-building capabilities
Real-time trigger alerts
Comprehensive company profiles
Valuable research and technology reports
Financial Statements
Dun & Bradstreet collects private company financials for more than 23 million companies worldwide. Find out more.
Financial data as of December 31, 2024 (12 month period) in USD
Annual Revenue 2024
$692.13 million
USD
Actual
1 USD = 0.9456 EUR
All financial statement data is in millions except per share data | Source: Morningstar
| Cash Flow (mil) | 2024 | 2023 | 2022 |
|---|---|---|---|
| Net Operating Cash | $108 | $104 | $91 |
| Net Investing Cash | -$118 | -$80 | -$21 |
| Net Financing Cash | $14 | -$33 | -$36 |
| Net Change in Cash | $4 | -$9 | $34 |
| Cash at Beginning of Period | $49 | $59 | $26 |
| Cash at End of Period | $52 | $49 | $59 |
| Capital Expenditure | -$95 | -$80 | -$81 |
| Assets (mil) | 2024 | 2023 | 2022 |
|---|---|---|---|
| Current Assets | |||
| Cash and Cash Equivalents | $52 | $49 | $59 |
| Accounts Receivable | $197 | $185 | $160 |
| Inventories | $7 | $6 | $7 |
| Other Current Assets | $128 | $108 | $92 |
| Asset Summary | |||
| Total Current Assets | $384 | $348 | $318 |
| Tangible Fixed Assets | $153 | $147 | $139 |
| Intangible Assets | $202 | $205 | $199 |
| Total Assets | $987 | $924 | $890 |
| Liabilities (mil) | 2024 | 2023 | 2022 |
|---|---|---|---|
| Current Liabilities | |||
| Accounts Payable | $76 | $65 | $59 |
| Short-Term Debt | $ | $ | $ |
| Other Current Liabilities | $311 | $276 | $245 |
| Liability Summary | |||
| Total Current Liabilities | $387 | $342 | $304 |
| Long-Term Debt | $ | $ | $ |
| Other Long-Term Liabilities | $0 | $ | $ |
| Total Liabilities | $745 | $666 | $619 |
| Stakeholder's Equity (mil) | 2024 | 2023 | 2022 |
|---|---|---|---|
| Equity | |||
| Common Stock | $14 | $14 | $14 |
| Retained Earnings | -$16 | -$8 | $14 |
| Equity Summary | |||
| Total Equity | $280 | $292 | $302 |
| Shares Outstanding | 13,714,184 | 13,577,555 | 13,608,106 |